Grade 8 (£40,792-£48,677) or Grade 9 (£51,630 - £58,089), Salary dependent on experience; Open ended contract
Drug Discovery Unit
One of the most prevalent cancer-causing genes or “oncogenes” is called PI3KCA. Damaging changes or “mutations” in this oncogene are found in many cancers including cancers of the breast, colon, brain, liver, stomach and lung. Understanding how cancer-causing genes such as PIK3CA change the behaviour of our cells is key to developing new therapies for cancer patients.
Last week, the School’s Annual Research Symposium was held at Crieff Hydro. The programme of talks and poster presentations covered the diverse research taking place in the School. Newly appointed Principal Investigators and Professors gave talks alongside more junior members of the School, who spoke as part of the SLS showcase sessions.
The University of Dundee Drug Discovery Unit announced a partnership with Takeda, Japan’s largest pharmaceutical company, to develop possible new therapeutic treatments for tau pathology, an underlying feature in several forms of neurodegeneration, including Alzheimer’s disease.
Researchers in the Wellcome Centre for Anti-Infectives Research (WCAIR) have been awarded £700,000 to investigate whether bacteria and other natural products found in the Amazon hold the key to developing new drugs for neglected tropical diseases. The team led by Professor Kevin Read will work with colleagues in Brazil to identify novel drug targets and develop new therapies for visceral leishmaniasis and Chagas’ disease.
A number of school prizes were presented at Review of the Year today.
Innovator of the Year
New for this year, Innovator of the Year, two categories were introduced for best innovation and for early-stage new business ideas. In partnership with the Centre of Entrepreneurship, the winners are guaranteed an automatic place in the appropriate category of the University of Dundee, Venture 2019 Final, plus a chance to participate in the on-campus three month summer Elevator accelerator programme.
Professor Mike Ferguson, Regius Professor of Life Sciences at the University of Dundee, has received a knighthood in the New Year’s Honours list. Professor Ferguson has been honoured for his service to science.
Parasitic protozoa called trypanosomes synthesize sugars using an unexpected metabolic pathway called gluconeogenesis, according to a new study published in the open-access journal PLOS Pathogens. The research led by Professor David Horn's team, in particular lead author Dr Julie Kovarova, in collaboration with Professors Mike Ferguson (Dundee) and Mike Barrett (Glasgow) note that this metabolic flexibility may be essential for adaptation to environmental conditions and survival in mammalian host tissues.